ANATARA LIFESCIENCES LTD - Announcements

0.00%

0.8¢

Market Cap $1.708M

Healthcare Biotechnology

Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is... Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.More

Announcements

Filter Results

All Price Sensitive Only

ANR	Notification of cessation of securities - ANR		18/08/25	12.86KB	Share
ANR	Appendix 4E & Financial Report 30 June 2025	PRICE SENSITIVE	13/08/25	1.04MB	Share
ANR	Application for quotation of securities - ANR		04/08/25	15.79KB	Share
ANR	Conversion of Performance Rights		04/08/25	206.98KB	Share
ANR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/25	649.95KB	Share
ANR	Anatara receives $969,455 in R&D Tax Incentive for FY25	PRICE SENSITIVE	28/07/25	166.75KB	Share
ANR	Company Update	PRICE SENSITIVE	09/07/25	290.95KB	Share
ANR	Change in substantial holding from TEK		01/07/25	143.92KB	Share
ANR	Hong Kong Patent Granted for GaRP	PRICE SENSITIVE	19/05/25	232.29KB	Share
ANR	Phase II GaRP-IBS Trial Internal Analyses of Data Subsets	PRICE SENSITIVE	16/05/25	1.01MB	Share
ANR	Funding Advance on R&D Refund	PRICE SENSITIVE	01/05/25	228.33KB	Share
ANR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/25	479.16KB	Share
ANR	Phase II GaRP-IBS Trial Headline Analysis of Results	PRICE SENSITIVE	17/04/25	370.8KB	Share
ANR	Phase II GaRP-IBS Trial & Anti-Obesity Project Updates	PRICE SENSITIVE	10/03/25	291.45KB	Share
ANR	Final Director's Interest Notice		07/03/25	132.58KB	Share
ANR	Initial Director's Interest Notice		07/03/25	132.87KB	Share
ANR	Trading Halt	PRICE SENSITIVE	06/03/25	257.29KB	Share
ANR	Board Changes		28/02/25	165.24KB	Share
ANR	Appendix 4D & Half Year Report 31 December 2024	PRICE SENSITIVE	25/02/25	548.16KB	Share
ANR	Phase II GaRP-IBS Trial & Anti-Obesity Project Updates	PRICE SENSITIVE	20/02/25	289.42KB	Share
ANR	Australian Patent Granted for GaRP Product	PRICE SENSITIVE	28/01/25	284.34KB	Share
ANR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	15/01/25	522.33KB	Share
ANR	Notification regarding unquoted securities - ANR		24/12/24	17.57KB	Share
ANR	Change of Director's Interest Notice		24/12/24	207.03KB	Share
ANR	Addendum to Company Presentation released on 2 December 2024		23/12/24	316.51KB	Share
ANR	Application for quotation of securities - ANR		23/12/24	15.67KB	Share
ANR	Share Purchase Plan Results		20/12/24	221.21KB	Share
ANR	GaRP-IBS Clinical Trial Update	PRICE SENSITIVE	13/12/24	283.75KB	Share
ANR	GaRP-IBS Clinical Trial Update	PRICE SENSITIVE	04/12/24	305.99KB	Share
ANR	Webinar and Q&A		02/12/24	206.89KB	Share
ANR	Investor Presentation		02/12/24	4.68MB	Share
ANR	Company Secretary Appointment/Resignation		29/11/24	163.95KB	Share
ANR	Share Purchase Plan Shareholder Letter		27/11/24	302.85KB	Share
ANR	Share Purchase Plan Offer Booklet	PRICE SENSITIVE	27/11/24	373.89KB	Share
ANR	Cleansing Notice		27/11/24	145.54KB	Share
ANR	Change in substantial holding from Tiga Trading Pty Ltd		22/11/24	155KB	Share
ANR	Change in substantial holding from TEK		22/11/24	172.39KB	Share
ANR	Cleansing Notice		22/11/24	169.44KB	Share
ANR	Application for quotation of securities - ANR		22/11/24	15.6KB	Share
ANR	Change of Director's Interest Notice		20/11/24	164.08KB	Share
ANR	Notification regarding unquoted securities - ANR		18/11/24	16.25KB	Share
ANR	Update - Proposed issue of securities - ANR		15/11/24	15.83KB	Share
ANR	ANR Increase in Placement		15/11/24	172.58KB	Share
ANR	Proposed issue of securities - ANR		15/11/24	16.28KB	Share
ANR	Proposed issue of securities - ANR		15/11/24	18.24KB	Share
ANR	Proposed issue of securities - ANR		15/11/24	15.44KB	Share
ANR	Successful Placement of $660k and Share Purchase Plan	PRICE SENSITIVE	15/11/24	173.7KB	Share
ANR	Results of Meeting		14/11/24	317.59KB	Share
ANR	Chair's Address to Shareholders	PRICE SENSITIVE	14/11/24	176.07KB	Share
ANR	Trading Halt	PRICE SENSITIVE	13/11/24	547.71KB	Share
ANR	Pause in Trading	PRICE SENSITIVE	13/11/24	116.12KB	Share
ANR	Appendix 4C & Q1 FY25 Activities Report	PRICE SENSITIVE	31/10/24	520.43KB	Share
ANR	GaRP-IBS Irritable Bowel Syndrome Clinical Trial Update		17/10/24	310.65KB	Share
ANR	GaRP-IBS Irritable Bowel Syndrome Clinical Trial Update	PRICE SENSITIVE	08/10/24	315.22KB	Share
ANR	Appendix 4G and Corporate Governance Statement		02/10/24	502.98KB	Share
ANR	Annual Report to shareholders		02/10/24	6.08MB	Share
ANR	Notice of Annual General Meeting/Proxy Form		02/10/24	594.93KB	Share
ANR	European Patent Granted for GaRP Product Addendum		01/10/24	154.61KB	Share
ANR	Anatara's GaRP granted EU patent	PRICE SENSITIVE	20/09/24	233.81KB	Share
ANR	Anatara Annual General Meeting & Director Nominations		10/09/24	154.46KB	Share
ANR	GaRP Irritable Bowel Syndrome Clinical Trial Update	PRICE SENSITIVE	30/08/24	305.09KB	Share
ANR	$626,000 received in R&D Tax Incentive for FY24	PRICE SENSITIVE	29/08/24	168.61KB	Share
ANR	Appendix 4E & Financial Report 30 June 2024	PRICE SENSITIVE	22/08/24	808.14KB	Share
ANR	Notification regarding unquoted securities - ANR		09/08/24	16.14KB	Share
ANR	Appendix 4C & Q4 FY24 Activities Report	PRICE SENSITIVE	30/07/24	564.9KB	Share
ANR	Change of Director's Interest Notice		12/07/24	356.45KB	Share
ANR	Notification regarding unquoted securities - ANR		11/07/24	18.9KB	Share
ANR	Application for quotation of securities - ANR		09/07/24	15.66KB	Share
ANR	Results of Meeting		05/07/24	354.52KB	Share
ANR	IBS Clinical Trial Stage 2 recruitment is proceeding well		13/06/24	286.58KB	Share
ANR	Notice of General Meeting/Proxy Form		03/06/24	559.37KB	Share
ANR	ANR- Cleansing Notice		14/05/24	175.39KB	Share
ANR	Notification regarding unquoted securities - ANR		07/05/24	17.72KB	Share
ANR	Application for quotation of securities - ANR		07/05/24	15.73KB	Share
ANR	Proposed issue of securities - ANR		01/05/24	16.28KB	Share
ANR	Anatara successful placement for $1.0M	PRICE SENSITIVE	01/05/24	284.62KB	Share
ANR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	461.51KB	Share
ANR	Trading Halt	PRICE SENSITIVE	29/04/24	215.62KB	Share
ANR	Change in substantial holding		22/04/24	1.21MB	Share
ANR	Recruitment 5 sites for Pivotal IBS Clinical Trial Stage 2		09/04/24	344.83KB	Share
ANR	Recruitment for Pivotal Phase II IBS Clinical Trial Stage 2	PRICE SENSITIVE	29/02/24	286.25KB	Share
ANR	Appendix 4D & Half Year Report 31 December 2023	PRICE SENSITIVE	28/02/24	473.92KB	Share
ANR	Appendix 4C & Q2 FY24 Activities Report	PRICE SENSITIVE	24/01/24	652.83KB	Share
ANR	Cleansing Notice		18/12/23	174.68KB	Share
ANR	Application for quotation of securities - ANR		18/12/23	24.59KB	Share
ANR	Anatara finalises Entitlement Issue		18/12/23	133.8KB	Share
ANR	Change of Director's Interest Notice		13/12/23	218.69KB	Share
ANR	Change of Director's Interest Notice		12/12/23	214.1KB	Share
ANR	Cleansing Notice		11/12/23	176.37KB	Share
ANR	Application for quotation of securities - ANR		11/12/23	24.79KB	Share
ANR	Change of Director's Interest Notice		11/12/23	218.74KB	Share
ANR	Change of Director's Interest Notice		11/12/23	214.72KB	Share
ANR	Application for quotation of securities - ANR		08/12/23	24.98KB	Share
ANR	Entitlement Offer Results	PRICE SENSITIVE	07/12/23	199.22KB	Share
ANR	Notification of cessation of securities - ANR		04/12/23	21.63KB	Share
ANR	Letter to Ineligible Shareholders		13/11/23	147.76KB	Share
ANR	Letter to Eligible Shareholders		13/11/23	150.06KB	Share
ANR	Non-Renounceable Entitlement Offer Booklet	PRICE SENSITIVE	13/11/23	607.32KB	Share
ANR	Entitlement offer opens and dispatch of Offer Booklet	PRICE SENSITIVE	13/11/23	189.37KB	Share
ANR	Results of Meeting		10/11/23	357.67KB	Share

ANR Notification of cessation of securities - ANR
18/08/25		12.86KB	Share
ANR Appendix 4E & Financial Report 30 June 2025
13/08/25	PRICE SENSITIVE	1.04MB	Share
ANR Application for quotation of securities - ANR
04/08/25		15.79KB	Share
ANR Conversion of Performance Rights
04/08/25		206.98KB	Share
ANR Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25	PRICE SENSITIVE	649.95KB	Share
ANR Anatara receives $969,455 in R&D Tax Incentive for FY25
28/07/25	PRICE SENSITIVE	166.75KB	Share
ANR Company Update
09/07/25	PRICE SENSITIVE	290.95KB	Share
ANR Change in substantial holding from TEK
01/07/25		143.92KB	Share
ANR Hong Kong Patent Granted for GaRP
19/05/25	PRICE SENSITIVE	232.29KB	Share
ANR Phase II GaRP-IBS Trial Internal Analyses of Data Subsets
16/05/25	PRICE SENSITIVE	1.01MB	Share
ANR Funding Advance on R&D Refund
01/05/25	PRICE SENSITIVE	228.33KB	Share
ANR Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25	PRICE SENSITIVE	479.16KB	Share
ANR Phase II GaRP-IBS Trial Headline Analysis of Results
17/04/25	PRICE SENSITIVE	370.8KB	Share
ANR Phase II GaRP-IBS Trial & Anti-Obesity Project Updates
10/03/25	PRICE SENSITIVE	291.45KB	Share
ANR Final Director's Interest Notice
07/03/25		132.58KB	Share
ANR Initial Director's Interest Notice
07/03/25		132.87KB	Share
ANR Trading Halt
06/03/25	PRICE SENSITIVE	257.29KB	Share
ANR Board Changes
28/02/25		165.24KB	Share
ANR Appendix 4D & Half Year Report 31 December 2024
25/02/25	PRICE SENSITIVE	548.16KB	Share
ANR Phase II GaRP-IBS Trial & Anti-Obesity Project Updates
20/02/25	PRICE SENSITIVE	289.42KB	Share
ANR Australian Patent Granted for GaRP Product
28/01/25	PRICE SENSITIVE	284.34KB	Share
ANR Quarterly Activities/Appendix 4C Cash Flow Report
15/01/25	PRICE SENSITIVE	522.33KB	Share
ANR Notification regarding unquoted securities - ANR
24/12/24		17.57KB	Share
ANR Change of Director's Interest Notice
24/12/24		207.03KB	Share
ANR Addendum to Company Presentation released on 2 December 2024
23/12/24		316.51KB	Share
ANR Application for quotation of securities - ANR
23/12/24		15.67KB	Share
ANR Share Purchase Plan Results
20/12/24		221.21KB	Share
ANR GaRP-IBS Clinical Trial Update
13/12/24	PRICE SENSITIVE	283.75KB	Share
ANR GaRP-IBS Clinical Trial Update
04/12/24	PRICE SENSITIVE	305.99KB	Share
ANR Webinar and Q&A
02/12/24		206.89KB	Share
ANR Investor Presentation
02/12/24		4.68MB	Share
ANR Company Secretary Appointment/Resignation
29/11/24		163.95KB	Share
ANR Share Purchase Plan Shareholder Letter
27/11/24		302.85KB	Share
ANR Share Purchase Plan Offer Booklet
27/11/24	PRICE SENSITIVE	373.89KB	Share
ANR Cleansing Notice
27/11/24		145.54KB	Share
ANR Change in substantial holding from Tiga Trading Pty Ltd
22/11/24		155KB	Share
ANR Change in substantial holding from TEK
22/11/24		172.39KB	Share
ANR Cleansing Notice
22/11/24		169.44KB	Share
ANR Application for quotation of securities - ANR
22/11/24		15.6KB	Share
ANR Change of Director's Interest Notice
20/11/24		164.08KB	Share
ANR Notification regarding unquoted securities - ANR
18/11/24		16.25KB	Share
ANR Update - Proposed issue of securities - ANR
15/11/24		15.83KB	Share
ANR ANR Increase in Placement
15/11/24		172.58KB	Share
ANR Proposed issue of securities - ANR
15/11/24		16.28KB	Share
ANR Proposed issue of securities - ANR
15/11/24		18.24KB	Share
ANR Proposed issue of securities - ANR
15/11/24		15.44KB	Share
ANR Successful Placement of $660k and Share Purchase Plan
15/11/24	PRICE SENSITIVE	173.7KB	Share
ANR Results of Meeting
14/11/24		317.59KB	Share
ANR Chair's Address to Shareholders
14/11/24	PRICE SENSITIVE	176.07KB	Share
ANR Trading Halt
13/11/24	PRICE SENSITIVE	547.71KB	Share
ANR Pause in Trading
13/11/24	PRICE SENSITIVE	116.12KB	Share
ANR Appendix 4C & Q1 FY25 Activities Report
31/10/24	PRICE SENSITIVE	520.43KB	Share
ANR GaRP-IBS Irritable Bowel Syndrome Clinical Trial Update
17/10/24		310.65KB	Share
ANR GaRP-IBS Irritable Bowel Syndrome Clinical Trial Update
08/10/24	PRICE SENSITIVE	315.22KB	Share
ANR Appendix 4G and Corporate Governance Statement
02/10/24		502.98KB	Share
ANR Annual Report to shareholders
02/10/24		6.08MB	Share
ANR Notice of Annual General Meeting/Proxy Form
02/10/24		594.93KB	Share
ANR European Patent Granted for GaRP Product Addendum
01/10/24		154.61KB	Share
ANR Anatara's GaRP granted EU patent
20/09/24	PRICE SENSITIVE	233.81KB	Share
ANR Anatara Annual General Meeting & Director Nominations
10/09/24		154.46KB	Share
ANR GaRP Irritable Bowel Syndrome Clinical Trial Update
30/08/24	PRICE SENSITIVE	305.09KB	Share
ANR $626,000 received in R&D Tax Incentive for FY24
29/08/24	PRICE SENSITIVE	168.61KB	Share
ANR Appendix 4E & Financial Report 30 June 2024
22/08/24	PRICE SENSITIVE	808.14KB	Share
ANR Notification regarding unquoted securities - ANR
09/08/24		16.14KB	Share
ANR Appendix 4C & Q4 FY24 Activities Report
30/07/24	PRICE SENSITIVE	564.9KB	Share
ANR Change of Director's Interest Notice
12/07/24		356.45KB	Share
ANR Notification regarding unquoted securities - ANR
11/07/24		18.9KB	Share
ANR Application for quotation of securities - ANR
09/07/24		15.66KB	Share
ANR Results of Meeting
05/07/24		354.52KB	Share
ANR IBS Clinical Trial Stage 2 recruitment is proceeding well
13/06/24		286.58KB	Share
ANR Notice of General Meeting/Proxy Form
03/06/24		559.37KB	Share
ANR ANR- Cleansing Notice
14/05/24		175.39KB	Share
ANR Notification regarding unquoted securities - ANR
07/05/24		17.72KB	Share
ANR Application for quotation of securities - ANR
07/05/24		15.73KB	Share
ANR Proposed issue of securities - ANR
01/05/24		16.28KB	Share
ANR Anatara successful placement for $1.0M
01/05/24	PRICE SENSITIVE	284.62KB	Share
ANR Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	461.51KB	Share
ANR Trading Halt
29/04/24	PRICE SENSITIVE	215.62KB	Share
ANR Change in substantial holding
22/04/24		1.21MB	Share
ANR Recruitment 5 sites for Pivotal IBS Clinical Trial Stage 2
09/04/24		344.83KB	Share
ANR Recruitment for Pivotal Phase II IBS Clinical Trial Stage 2
29/02/24	PRICE SENSITIVE	286.25KB	Share
ANR Appendix 4D & Half Year Report 31 December 2023
28/02/24	PRICE SENSITIVE	473.92KB	Share
ANR Appendix 4C & Q2 FY24 Activities Report
24/01/24	PRICE SENSITIVE	652.83KB	Share
ANR Cleansing Notice
18/12/23		174.68KB	Share
ANR Application for quotation of securities - ANR
18/12/23		24.59KB	Share
ANR Anatara finalises Entitlement Issue
18/12/23		133.8KB	Share
ANR Change of Director's Interest Notice
13/12/23		218.69KB	Share
ANR Change of Director's Interest Notice
12/12/23		214.1KB	Share
ANR Cleansing Notice
11/12/23		176.37KB	Share
ANR Application for quotation of securities - ANR
11/12/23		24.79KB	Share
ANR Change of Director's Interest Notice
11/12/23		218.74KB	Share
ANR Change of Director's Interest Notice
11/12/23		214.72KB	Share
ANR Application for quotation of securities - ANR
08/12/23		24.98KB	Share
ANR Entitlement Offer Results
07/12/23	PRICE SENSITIVE	199.22KB	Share
ANR Notification of cessation of securities - ANR
04/12/23		21.63KB	Share
ANR Letter to Ineligible Shareholders
13/11/23		147.76KB	Share
ANR Letter to Eligible Shareholders
13/11/23		150.06KB	Share
ANR Non-Renounceable Entitlement Offer Booklet
13/11/23	PRICE SENSITIVE	607.32KB	Share
ANR Entitlement offer opens and dispatch of Offer Booklet
13/11/23	PRICE SENSITIVE	189.37KB	Share
ANR Results of Meeting
10/11/23		357.67KB	Share

REFRESH

1 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $1.708M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.8¢	$1.2K	150K

Buyers (Bids)

No.	Vol.	Price($)
1	238922	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	1408675	4

View Market Depth

No.	Vol.	Price($)
1	238922	0.008
7	1177170	0.007
9	2276169	0.006
10	3812000	0.005
6	3500052	0.004

Price($)	Vol.	No.
0.009	1408675	4
0.010	1502600	4
0.011	520150	2
0.012	755000	2
0.013	300000	1

Last trade - 10.02am 03/09/2025 (20 minute delay)

ANR (ASX) Chart

ANATARA LIFESCIENCES LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories